SCHEMBL23019016

SCHEMBL23019016

CNc1c(N)ncnc1N(C=O)Cc1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.35
▸ LMNA P02545 2/20 0.34
▸ RPS6KB1 P23443 3/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ TSHR P16473 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ DRD1 P21728 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19945526 0.79 ADORA3 (0.36) LMNARAB9AKDM4EHTTALDH1A1
SCHEMBL23771842 0.74 ALDH1A1 (0.35) LMNARPS6KB1RAB9AHTTALDH1A1
SCHEMBL19945803 0.71 ALDH1A1 (0.33) ALDH1A1
SCHEMBL19945798 0.70 KCNQ3 (0.32) LMNAKDM4ECYP1A2ADRA2ACYP2D6
SCHEMBL19945786 0.69 RAB9A (0.37) LMNARAB9AKDM4EALDH1A1
SCHEMBL27249668 0.68 FAAH (0.30) —
SCHEMBL21318947 0.67 USP28 (0.39) LMNAALDH1A1
SCHEMBL19945779 0.67 MEN1 (0.36) LMNARAB9ATSHRKDM4EHTT
SCHEMBL21318984 0.66 KMT2A (0.34) LMNARAB9AHTTCYP1A2ADRA2A
SCHEMBL21318963 0.66 TSHR (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3970750-A1 COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR F. Hoffmann-La Roche AG (CH) 2022-03-23 — — EP disclosed
EP-3504210-B1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2021-02-24 — — EP disclosed
Send feedback